Document is current

Article History

Received: 17 July 2023

Accepted: 19 March 2024

First Online: 29 March 2024

Declarations

:

: This study was approved by the National Commission of Ethics in Research (CONEP—Comissão Nacional de Ética em Pesquisa)—Ministry of Health. The coordinating center was the University of the State of Rio de Janeiro, and the approval number was 45781015.8.1001.5259. Each of the centers also obtained approval from the respective Institutional Review Boards. All patients signed the informed consent form.

: Not applicable.

: Ana Luisa Bagno de Almeida 1 (MD)—none. Maria Fernanda B. Resende Guimarães 1 (MD, PhD)—personal fees and/or nonfinancial support from AbbVie, Bristol-Myers-Squibb, Janssen, Novartis, Pfizer, Roche and UCB. Maria Raquel da Costa Pinto 1 (MD, PhD)—none. Letícia Rocha Pereira 2 (MSc, PhD candidate)—none. Ana Paula Monteiro Gomides Reis 3—none (MD, PhD). Karina Rossi Bonfiglioli 4 (MD, PhD)—personal fees and/or nonfinancial support from Abbvie, Boheringer Ingelheim, Bristol-Myers-Squibb, Janssen, Novartis and Roche. Paulo Louzada-Junior 5 (MD, PhD)—none. Rina Dalva Neubarth Giorgi 6 (MD, MSc)—personal fees and/or nonfinancial support from AbbVie, Bristol-Myers-Squibb, Eli Lilly, Janssen and UCB. Gláucio Ricardo Werner de Castro 7 (MD, PhD)—none. Sebastião Cezar Radominski 8 (MD, PhD)—consulting fees, speaking fees and institutional support for clinical trials from AbbVie, Amgen, Bristol-Myers-Squibb, Lilly, Pfizer, and Roche. Claiton Viegas Brenol 9 (MD, PhD)—personal fees and/or nonfinancial support from AbbVie, Bristol-Myers-Squibb, Janssen, Novartis, Pfizer, Roche and UCB. Alisson Pugliesi 10 (MD)—none. Licia Maria Henrique da Mota 3 (MD, Ph. D)—personal or institutional support from AbbVie, Janssen, Pfizer and Roche; has delivered speeches at events related to this work and sponsored by AbbVie, Boehringer Ingelheim, GSK, Janssen, Libbs, Lilly, Novartis, Pfizer, Roche, Sandoz, and UCB. Geraldo da Rocha Castelar-Pinheiro 2 (MD, PhD, Full Professor)—none.